We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GelStat Signs Distribution Agreement With Windmill Health Products for the Distribution of "Chews 2 Lose" Appetite Suppressant Gum Windmill Health Products Is Initially Placing Chews 2 Lose in...
GelStat Corporation Signs Binding Definitive Agreement to Acquire Mastix Medica, LLC Acquisition Expected to Add $2.0 Million in Revenue in the 2nd Half of 2014 PALM CITY, FL--(Marketwired...
UPDATE: GelStat Corporation Launches Chews 2 Lose, Its New Appetite Suppressant Gum Chews 2 Lose Targets an Estimated 75 Million+ Dieters and Is Compatible With Any Weight-loss Plan...
GelStat Corporation Launches Chews 2 Lose, Its New Appetite Suppressant Gum Chews 2 Lose Targets an Estimated 75 Million+ Dieters and Is Compatible With Any Weight-loss Plan PALM...
Roger Cady, M.D. Joins GelStat Corporation as Chief Medical Advisor Dr. Cady Will Be Assisting GelStat With Developing Several of the Company's New Migraine Products PALM CITY...
PALM CITY, FL--(Marketwired - June 10, 2013) - GelStat Corporation (PINKSHEETS: GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0001 | 33.3333333333 | 0.0003 | 0.0004 | 0.0003 | 1012889 | 0.0003998 | CS |
4 | 0.0001 | 33.3333333333 | 0.0003 | 0.0005 | 0.0003 | 6859760 | 0.00039294 | CS |
12 | 0.0001 | 33.3333333333 | 0.0003 | 0.0005 | 0.0003 | 4841118 | 0.0003849 | CS |
26 | -0.0001 | -20 | 0.0005 | 0.0005 | 0.0003 | 4321643 | 0.00037531 | CS |
52 | 0.0001 | 33.3333333333 | 0.0003 | 0.0006 | 0.0002 | 6206199 | 0.00039604 | CS |
156 | -0.0101 | -96.1904761905 | 0.0105 | 0.0185 | 0.0001 | 13678315 | 0.00061973 | CS |
260 | -0.0011 | -73.3333333333 | 0.0015 | 0.08 | 0.0001 | 9353535 | 0.0007287 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions